Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
News this morning roche and abbot is the antibody test with no false negatives being rolled out by the government.
Also said the finger test ones from other companys threw up false negatives.
Im not sure how this affects us.
Plus, antibody tests will remain complementary to antigen tests ; although they'll mean antigen tests will lose the monopoly they enjoy right now.
What we'll have to pay attention to is a : quick, reliable, self-administered and cheap antigen test.
This is a very tough combination to crack. See Intermed's test - which checks pretty much everything listed above... except its reliability is rubbish.
Id like to think we are ingenious enough and innovated enough to stay ahead of the curve regards tests.
I think of the song
“Anything you can do we can do better”
I dont feel the need to jump ship within this sector.
I do however wish to free up a marginal percentage to get into another area.
There are many opportunities available and i like to spread my roll in diverse markets.
I am comfortable here but my expectations have withered and i cannot understand why.
"I am comfortable here but my expectations have withered and i cannot understand why."
I think it's because we haven't gotten a sales RNS in a (relatively) long time. Which has caused many to lose faith.
All I can say is : hold on till the next RNS fam, and see how you feel then. If your faith hasn't been rekindled, then sell a chunk of your shares.
" think it's because we haven't gotten a sales RNS in a (relatively) long time."
It was just the end of last month!
I don't think the issue is the length of time since we have a sales update; the issue is that we have not have a sales/orders update commensurate with the content of the last three rns(s). this appears to be a particular problem for the market and the reason why the last great rns bombed!
sorry about the typos!
Your typos arent losing us money.
I winder if maybe “our graham” has been ill.
As he bought some shares last week, I would assume all is ok with him.
I wondered if he was just trying to put a little "Time" distance between his share purchase and a Sales/Orders RNS, in case people put 2+2 = 5, (perhaps there is even a rule for information being disclosed after a Directors purchase?)
The fact we agreed a huge deal with Egypt of 40000 kits, equal to 3.96 million tests, and did not get an rns brought me a lot of comfort and led me to buy back in last week. If orders of this magnitude are not deemed newsworthy enough for an rns then there is absolutely no reason to worry IMO. It means these sorts of deals (maybe not quite as large) are ongoing and Graham has decided to save it all up for the monthly sales update.
I’m still not convinced it’s 40,000 test kits. I would count revenue from 40,000 tests rather than think we’ve bagged £30M revenue we might not have.
This may have been on here before re Egypt and testing but it does say” test kits” and not tests
https://www.gov.uk/government/news/uk-company-delivers-over-40000-pcr-test-kits-to-egypt
Test kits 40,000 x 96 = 3,840,000 x £8.70
Tests 40,000 x £8.70
Its its as easy as that, Test kits, Tests.
Handyman, I know they used the phrase tests kits but is the person that wrote that going to know there’s 96 tests per kit? From a PR perspective wouldn’t they have been better saying we supplied Egypt with 3.8M tests if that’s what we supplied?
I think we’re better assuming it was 40,000 tests rather than be disappointed if the next sales update is £30M less than expected. If it’s higher than expected happy days.
The press release clearly stated test kits, so why would it be tests? It’s more than likely they’ve negotiated a deal based on volume so the price will be lower than usual. I very much doubt we’ll get specifics for this or any other large deals as providing price per test undermines negotiations with the hundreds of other parties they’ll be dealing with.
Ok we can agree to disagree.
Not that it matters as we’ll be selling everything we make anyway.
I know what you’re saying Anders and I tend to agree but 40,000 tests... We get through that in half a day!!
I totally agree with you that we will not value specifics for each deal for the reasons you mentioned .Also as we are mostly dealing with government agencies they will not want to see that another country has negotiated a better deal and therefore lose face with their voters
In addition, 40,000 tests in a population of 102m won’t even scratch the surface - almost certain it’s 3.5m.
Plus the divisory numbers wouldn’t stack up
If there’s 96 tests in a test kit and they’d only negotiated 40000 TESTS then that would equate to 416.666 test kits which is obviously an odd number... but who knows :)
Generally these sort of lab products are sold in kits and would expect it to be a multiple of the testing plate ie 96 or whatever. Strongly think it is kits that are sold, not individual tests.
Handyman got there first
Egypt has a population of 98 Million. UK 66million. UK is doing over 100,000 tests per day.
40,000 tests only for Egypt is a drop in the ocean. It says KITS...got to be kits.
We’ll see in the next sales update, I hope you’re right.
So do we !